Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Proof-Of-Concept Trial of Augmentation of Antidepressants by Low Dose Naltrexone (LDN) for Patients With Breakthrough Symptoms of Major Depressive Disorder on Antidepressant Therapy

NCT01874951 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01874951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01874951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Proof-Of-Concept Trial of Augmentation of Antidepressants by Low Dose Naltrexone (LDN) for Patients With Breakthrough Symptoms of Major Depressive Disorder on Antidepressant Therapy
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2013
Completion date
June 30, 2015
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, unipolar, major depressive disorder, recurrence, relapse